Viral DNA/RNA Purification Kit, IVD


Viral DNA and RNA purification from human plasma and serum for in vitro diagnostic use. Compatible with downstream qualitative and quantitative in vitro diagnostic workflows, such as PCR, qPCR, RT-PCR, and RT-qPCR.
  
Loading...

The Thermo Scientific Viral DNA/RNA Purification Kit is a simple and easy-to-use system for efficient purification of viral nucleic acids from human plasma or serum samples for in vitro diagnostic purposes.

The purification system utilizes silica-based membrane technology in the convenient form of a spin column. The entire purification procedure takes approximately 30 minutes to process 1 to 4 samples. Purified viral DNA and RNA are compatible with downstream qualitative and quantitative in vitro diagnostic workflows, such as PCR, qPCR, RT-PCR, and RT-qPCR. The kit is compatible with citrate- or EDTA-treated human plasma and serum samples. To avoid sample contamination and to ensure safe waste handling, fresh wash tubes are supplied for each wash step.

Highlights

  • Efficient purification of viral DNA and RNA from a wide range of virus concentrations
  • Compatible with fresh or frozen serum and plasma preserved with EDTA or citrate
  • Minimized risk of cross-contamination
  • CE-marked for compliance with EU Directive 98/79/EC

Applications

  • Isolation of viral nucleic acids from 200 µL of fresh or frozen human plasma and serum samples preserved with either EDTA or citrate
  • Downstream use in in vitro diagnostic qualitative and quantitative nucleic acid based assays (e.g. PCR, RT-PCR)

Includes

  • Column Preparation Liquid
  • Lysis Solution
  • Wash Buffer 1 (concentrated)
  • Wash Buffer 2 (concentrated)
  • Eluent
  • Proteinase K
  • Carrier RNA
  • Lysis Tubes (1.5 mL)
  • Spin Columns preassembled with Wash Tubes
  • Wash Tubes (2 mL)
  • Elution Tubes (1.5 mL)
  • Handbook

Principle

During the purification procedure, viral nucleic acids from lysed plasma or serum samples bind to the column membrane while impurities are effectively removed during subsequent wash steps. Ready-to-use nucleic acids are then eluted from the column. The purified viral nucleic acids are free of proteins, nucleases, and other contaminants or inhibitors of downstream applications.

  
Storage ConditionAmbient
HazardousNo
Elution volume50 μL
FormatSpin columns
Preparation time≥ 30 minutes
Quality Control
  • The Viral DNA/RNA Purification Kit is produced in compliance with Directive 98/79/EC requirements.
  • The quality of the product is controlled using validated procedures.
  • In accordance with our Company Quality Management System, each lot of the Viral DNA/RNA Purification Kit is tested against predetermined specifications to ensure consistent product quality.
SampleHuman serum or plasma, fresh or frozen, treated with EDTA or citrate
Sample volume200 μL
TechnologySilica-membrane technology
Virus typesDNA, RNA
Overview of purification procedure

Overview of purification procedure

Overview of purification procedure

Figure 1.


Linear performance across a wide viral nucleic acid concentration range

Linear performance across a wide viral nucleic acid concentration range

Linear performance across a wide viral nucleic acid concentration range

Figure 2.Real-time PCR detection of Viral RNA (A) and DNA (B) purified with the Viral DNA/RNA Purification Kit. Samples of various HBV and HCV titers were produced by diluting infected plasma of known viral titer with non-infected plasma.

A: Detection of RNA from various HCV sample titers.
B: Detection of DNA from various HBV sample titers.


Reproducible results at low and high viral titers

Reproducible results at low and high viral titers

Reproducible results at low and high viral titers

Figure 3.Isolation of viral nucleic acids from multiple replicates of two plasma samples infected with high and low HCV (A) or HBV (B) titers using the Viral DNA/RNA Purification Kit. Isolated HCV and HBV nucleic acids were quantified using a real-time PCR detection assay.

A: Detection of RNA from multiple replicates of HCV plasma samples with high and low viral titers.
B: Detection of DNA from multiple replicates of HBV plasma samples with high and low viral titers.